These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24737621)

  • 1. Stochastic variation in network epidemic models: implications for the design of community level HIV prevention trials.
    Boren D; Sullivan PS; Beyrer C; Baral SD; Bekker LG; Brookmeyer R
    Stat Med; 2014 Sep; 33(22):3894-904. PubMed ID: 24737621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size considerations in the design of cluster randomized trials of combination HIV prevention.
    Wang R; Goyal R; Lei Q; Essex M; De Gruttola V
    Clin Trials; 2014 Jun; 11(3):309-318. PubMed ID: 24651566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.
    Johnson WD; Diaz RM; Flanders WD; Goodman M; Hill AN; Holtgrave D; Malow R; McClellan WM
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001230. PubMed ID: 18646068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to manage the HIV epidemic in gay, bisexual, and other men who have sex with men.
    Beyrer C
    Curr Opin Infect Dis; 2014 Feb; 27(1):1-8. PubMed ID: 24345924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation Model.
    Nakagawa F; van Sighem A; Thiebaut R; Smith C; Ratmann O; Cambiano V; Albert J; Amato-Gauci A; Bezemer D; Campbell C; Commenges D; Donoghoe M; Ford D; Kouyos R; Lodwick R; Lundgren J; Pantazis N; Pharris A; Quinten C; Thorne C; Touloumi G; Delpech V; Phillips A;
    Epidemiology; 2016 Mar; 27(2):247-56. PubMed ID: 26605814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of heterogeneity on HIV prevention trials.
    Auvert B; Sitta R; Zarca K; Mahiane SG; Pretorius C; Lissouba P
    Clin Trials; 2011 Apr; 8(2):144-54. PubMed ID: 21478327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the UNAIDS 90-90-90 treatment cascade for gay, bisexual and other men who have sex with men in South Africa: using the findings of a data triangulation process to map a way forward.
    Scheibe A; Grasso M; Raymond HF; Manyuchi A; Osmand T; Lane T; Struthers H
    AIDS Behav; 2018 Mar; 22(3):853-859. PubMed ID: 28444469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized community-level HIV prevention intervention trial for men who drink in South African alcohol-serving venues.
    Kalichman SC; Simbayi LC; Cain D; Carey KB; Carey MP; Eaton L; Harel O; Mehlomakhulu V; Mwaba K
    Eur J Public Health; 2014 Oct; 24(5):833-9. PubMed ID: 24248803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global epidemiology of HIV infection in men who have sex with men.
    Beyrer C; Baral SD; van Griensven F; Goodreau SM; Chariyalertsak S; Wirtz AL; Brookmeyer R
    Lancet; 2012 Jul; 380(9839):367-77. PubMed ID: 22819660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sectional human immunodeficiency virus incidence estimation accounting for heterogeneity across communities.
    Xu Y; Laeyendecker O; Wang R
    Biometrics; 2019 Sep; 75(3):1017-1028. PubMed ID: 30746695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of alternative study designs on the power of community randomized trials: evidence from three studies of human immunodeficiency virus prevention in East Africa.
    Todd J; Carpenter L; Li X; Nakiyingi J; Gray R; Hayes R
    Int J Epidemiol; 2003 Oct; 32(5):755-62. PubMed ID: 14559745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV prevention interventions with gay or bisexual men and youth.
    Kelly JA
    AIDS; 2000 Sep; 14 Suppl 2():S34-9. PubMed ID: 11061640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV risk and prevention among men who have sex with men in rural South Africa.
    Maleke K; Makhakhe N; Peters RP; Jobson G; De Swardt G; Daniels J; Lane T; McIntyre JA; Imrie J; Struthers H
    Afr J AIDS Res; 2017 Mar; 16(1):31-38. PubMed ID: 28367747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual Networks and HIV Risk among Black Men Who Have Sex with Men in 6 U.S. Cities.
    Tieu HV; Liu TY; Hussen S; Connor M; Wang L; Buchbinder S; Wilton L; Gorbach P; Mayer K; Griffith S; Kelly C; Elharrar V; Phillips G; Cummings V; Koblin B; Latkin C;
    PLoS One; 2015; 10(8):e0134085. PubMed ID: 26241742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa.
    Malahleha M; Laher F; Dilraj A; Smith P; Gray GE; Grove D; Odhiambo JA; Andrasik MP; Grunenberg NA; Moodie Z; Huang Y; Borate BR; Gillespie KM; Allen M; Atujuna M; Singh N; Kalonji D; Meintjes G; Kotze P; Bekker LG; Janes H
    AIDS Behav; 2023 Sep; 27(9):3027-3037. PubMed ID: 36929319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving the UNAIDS 90-90-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan Africa.
    Sabapathy K; Balzer L; Larmarange J; Block L; Floyd S; Iwuji C; Wirth K; Ayles H; Fidler S; Kamya M; Petersen M; Havlir D; Dabis F; Moore J; Hayes R
    BMC Public Health; 2022 Dec; 22(1):2333. PubMed ID: 36514036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-based HIV prevalence in KwaZulu-Natal, South Africa: results of a cross-sectional household survey.
    Kharsany ABM; Cawood C; Khanyile D; Lewis L; Grobler A; Puren A; Govender K; George G; Beckett S; Samsunder N; Madurai S; Toledo C; Chipeta Z; Glenshaw M; Hersey S; Abdool Karim Q
    Lancet HIV; 2018 Aug; 5(8):e427-e437. PubMed ID: 30021700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 1. Design.
    Hayes R; Mosha F; Nicoll A; Grosskurth H; Newell J; Todd J; Killewo J; Rugemalila J; Mabey D
    AIDS; 1995 Aug; 9(8):919-26. PubMed ID: 7576328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination HIV prevention among MSM in South Africa: results from agent-based modeling.
    Brookmeyer R; Boren D; Baral SD; Bekker LG; Phaswana-Mafuya N; Beyrer C; Sullivan PS
    PLoS One; 2014; 9(11):e112668. PubMed ID: 25398143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.